Circulation · 2003 · 415 citations · 21 references
MedicineMolecular GeneticsPharmacologyPharmacodynamicsPharmacogeneticsPharmacogenomicsGenotype-phenotype CorrelationPlatelet ActivationPlatelet AggregationPlatelet FunctionPlatelet PhysiologyReceptor PolymorphismsAdenosine Diphosphate Receptor BlockadeAdenosine Diphosphate-induced Platelet AggregationAdenosine Receptor SignalingPlatelet Aggregation DefectsPlatelet Aggregation InhibitionPlatelet Reactivity GeneticsPlatelet Responses To AgonistsPlatelet Surface Receptors
The ADP receptor P2Y12 is essential for platelet aggregation, and its blockade benefits cardiovascular patients, yet interindividual variability in ADP‑induced aggregation remains unexplained. The study aimed to screen the P2Y12 gene for sequence variations that might explain this variability. Researchers measured ADP‑induced aggregation in 98 healthy volunteers, identified high‑ and low‑responders, and genotyped the P2Y12 gene for polymorphisms. Four common P2Y12 polymorphisms form two haplotypes (H1, H2) with H2 frequency 0.14, and the number of H2 alleles correlates with higher ADP‑induced aggregation and greater cAMP downregulation, indicating that H2 carriers may have increased atherothrombotic risk and reduced response to antiplatelet therapy.
Background— The adenosine diphosphate (ADP) receptor P2Y 12 plays a pivotal role in platelet aggregation, as demonstrated by the benefit conferred by its blockade in patients with cardiovascular disease. Some studies have shown interindividual differences in ADP-induced platelet aggregation responses ex vivo, but the mechanisms underlying this variability are unknown. Methods and Results— We examined ADP-induced platelet aggregation responses in 98 healthy volunteers, and we identified 2 phenotypic groups of subjects with high and low responsiveness to 2 μmol/L ADP. This prompted us to screen the recently identified G i -coupled ADP receptor gene P2Y 12 for sequence variations. Among the 5 frequent polymorphisms thus identified, 4 were in total linkage disequilibrium, determining haplotypes H1 and H2, with respective allelic frequencies of 0.86 and 0.14. The number of H2 alleles was associated with the maximal aggregation response to ADP in the overall study population ( P =0.007). Downregulation of the platelet cAMP concentration by ADP was more marked in 10 selected H2 carriers than in 10 noncarriers. Conclusions— In healthy subjects, ADP-induced platelet aggregation is associated with a haplotype of the P2Y 12 receptor gene. Given the crucial role of the P2Y 12 receptor in platelet functions, carriers of the H2 haplotype may have an increased risk of atherothrombosis and/or a lesser clinical response to drugs inhibiting platelet function.
21
A Concordance Correlation Coefficient to Evaluate Reproducibility
Biometrics · 1989 · 8.7K citations
Identification of the platelet ADP receptor targeted by antithrombotic drugs
Gunther Hollopeter, Hans‐Michael Jantzen, D Vincent et al. · Nature · 2001 · 1.4K citations
Medicine, Hematology, Pharmacology +14